---
# === 基本資訊 ===
title: "Profluent"
slug: "profluent"
name_en: "Profluent"
name_zh: ""
logo: ""
founded:
headquarters: "美國"
country: "美國"
city: ""
website: "https://www.profluent.bio"
description_short: "Profluent運用AI設計新型蛋白質，包括用於"
description_long: |
  Profluent運用AI設計新型蛋白質，包括用於基因編輯的新酶，推動下一代治療方法的開發。

# === 分類 ===
category_primary: "垂直產業AI"
category_secondary: "醫療保健AI"
tags: ['醫療保健AI', '美國']

# === 財務/融資 ===
status: "private"
stock_ticker: ""
latest_valuation: "未公開"
total_funding: ""
latest_round: "Series A"
latest_round_amount: "35"
latest_round_date: ""

funding_rounds: []
#  - round: ""
#    date: ""
#    amount: ""
#    lead_investor: ""
#    valuation: ""

investors:
  - name: "Spark Capital"
    type: ""
  - name: "Insight Partners"
    type: ""
  - name: "AIX Ventures"
    type: ""

# === 產品/服務 ===
products: []
#  - name: ""
#    description: ""
#    url: ""

business_model: []
target_industries: []

# === 團隊 ===
founders: []
#  - name: ""
#    role: ""
#    people_slug: ""

current_ceo: ""
employee_count: ""

key_people: []
#  - name: ""
#    role: ""
#    people_slug: ""

# === 發展歷史 ===
milestones: []
#  - date: ""
#    event: ""

# === 社群連結 ===
social:
  twitter: ""
  linkedin: ""
  github: ""
  crunchbase: ""
  wikipedia: ""
  investor_relations: ""

# === 台灣關聯 ===
taiwan_relevance: |
  台灣生技製藥產業可關注Profluent的AI藥物開發技術，加速研發進程。

# === 元資料 ===
data_sources:
  - "Fortune 50 AI Innovators 2023"
last_updated: "2026-01-23"
update_notes: "從 Excel 名單批次匯入"

draft: false
---

Profluent運用AI設計新型蛋白質，包括用於基因編輯的新酶，推動下一代治療方法的開發。
